|
1 Indications And Usage Piqray Is Indicated In Combination With Fulvestrant For The Treatment Of Postmenopausal Women, And Men, With Hormone Receptor (Hr)-Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative, Pik3ca-Mutated, Advanced Or Metastatic Breast Cancer As Detected By An Fda-Approved Test Following Progression On Or After An Endocrine-Based Regimen. Piqray Is A Kinase Inhibitor Indicated In Combination With Fulvestrant For The Treatment Of Postmenopausal Women, And Men, With Hormone Receptor (Hr)-Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative, Pik3ca-Mutated, Advanced Or Metastatic Breast Cancer As Detected By An Fda-Approved Test Following Progression On Or After An Endocrine-Based Regimen.
|